Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 13 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trialNicholls, S.; Puri, R.; Anderson, T.; Ballantyne, C.; Cho, L.; Kastelein, J.; Koenig, W.; Somaratne, R.; Kassahun, H.; Yang, J.; Wasserman, S.; Scott, R.; Ungi, I.; Podolec, J.; Ophuis, A.; Cornel, J.; Borgman, M.; Brennan, D.; Nissen, S.
2014The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011Ray, K.; Kastelein, J.; Matthijs Boekholdt, S.; Nicholls, S.; Khaw, K.; Ballantyne, C.; Catapano, A.; Reiner, Ž.; Lüscher, T.
2014High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: Insights from SATURNStegman, B.; Puri, R.; Cho, L.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nissen, S.; Nicholls, S.
2012Effects of dalcetrapib in patients with a recent acute coronary syndromeSchwartz, G.; Olsson, A.; Ballantyne, C.; Abt, M.; Barter, P.; Brumm, J.; Chaitman, B.; Holme, I.; Kallend, D.; Leiter, L.; Leitersdorf, E.; McMurray, J.; Mundl, H.; Nicholls, S.; Shah, P.; Tardif, J.; Wright, R.
2013Factors underlying regression of coronary atheroma with potent statin therapyPuri, R.; Nissen, S.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; St. John, J.; Wolski, K.; Uno, K.; Kataoka, Y.; Nicholls, S.
2013Coronary atheroma volume and cardiovascular events during maximally intensive statin therapyPuri, R.; Nissen, S.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
2014Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from study of coronary atheroma by intravascular ultrasound: effect of rosuvastatin versus atorvastatinPuri, R.; Nissen, S.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
2017Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: the ACCENTUATE trialNicholls, S.; Ray, K.; Ballantyne, C.; Beacham, L.; Miller, D.; Ruotolo, G.; Nissen, S.; Riesmeyer, J.
2014Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURNPuri, R.; Nissen, S.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
2013C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapyPuri, R.; Nissen, S.; Libby, P.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.